Treating Blood Cancers Podcast Por Blood Cancer United arte de portada

Treating Blood Cancers

Treating Blood Cancers

De: Blood Cancer United
Escúchala gratis

OFERTA POR TIEMPO LIMITADO | Obtén 3 meses por US$0.99 al mes

$14.95/mes despues- se aplican términos.
Podcast Series for Professionals by Blood Cancer UnitedTreating Blood Cancers Podcast Series - Blood Cancer United Ciencia Enfermedades Físicas Higiene y Vida Saludable Historia Natural Naturaleza y Ecología
Episodios
  • Key Insights from Attending ASH 2025
    Jan 13 2026

    Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC

    Recorded on December 18, 2025


    Lore Gruenbaum, PhD
    Chief Scientific Officer & Senior Vice President of Research
    Blood Cancer United
    Washington, DC
    Join Dr. Lore Gruenbaum, Chief Scientific Officer and Senior Vice President of Research at Blood Cancer United, to provide practice-changing data in hematologic malignancies from the 67th American Society of Hematology (ASH) Annual Meeting. Explored are breakthroughs in multiple myeloma, AML, CLL, and advances in cell therapy. Discussion also covers the growing use of artificial intelligence to accelerate precision medicine, spotlighting the Blood Cancer United Beat AML® Master Clinical Trial as a model for AI-driven trial design and real-time clinical decision-making. Tune in today for the key takeaways you need to know!

    Additional Blood Cancer United Resources:

    • Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
    • Blood Cancer United Resources for Patients

    Más Menos
    34 m
  • Delivering Equitable Cancer Care: What Every Healthcare Professional Should Know
    Dec 17 2025

    Raymond Mailhot, MD, MPH, University of Miami, Miami, FL

    Recorded on December 2, 2025


    Raymond Mailhot, MD, MPH
    Department of Radiation Oncology
    University of Miami
    Miami, FL
    Join us with Dr. Raymond Mailhot from the University of Miami as we explore how social determinants of health shape patient experiences, treatment decisions, and outcomes. He discusses the importance of cultural competence in delivering equitable, patient-centered care and shares practical communication strategies to better engage patients and collaborate effectively. This episode offers actionable insights to strengthen relationships and improve overall care quality. Tune in today to gain practical strategies that will enhance your approach to patient-centered care and drive better outcomes!

    Additional Blood Cancer United Resources:

    • Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
    • Blood Cancer United Medical Debt Case Management Program for Patients
    • Blood Cancer United Additional Resources for Patients

    Más Menos
    31 m
  • Hairy Cell Leukemia: Strategies for Improved Patient Outcomes
    Nov 20 2025

    Paul J. Hampel, MD, Mayo Clinic, Rochester, MN

    Recorded on November 4, 2025


    Paul J. Hampel, MD
    Assistant Professor of Medicine
    Division of Hematology, Department of Medicine
    Mayo Clinic
    Rochester, MN
    In this episode, Dr. Paul Hampel from Mayo Clinic Rochester takes a comprehensive look at hairy cell leukemia (HCL). He reviews the current diagnostic work-up, including immunophenotypic and molecular testing, and highlights key clinical features that distinguish HCL from related disorders. Dr. Hampel also discusses approved frontline therapies and evidence-based approaches for relapsed or refractory disease, with attention to infection risk and supportive care. The conversation explores emerging agents, novel combinations, and clinical trials shaping the next wave of HCL management. Join us for this expert discussion, offering practical insights to enhance care and outcomes for patients with HCL.

    Más Menos
    40 m
Todavía no hay opiniones